Mucosal vaccines for SARS-CoV-2: triumph of hope over experience

Currently approved COVID-19 vaccines administered parenterally induce robust systemic humoral and cellular responses. While highly effective against severe disease, there is reduced effectiveness of these vaccines in preventing breakthrough infection and/or onward transmission, likely due to poor im...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilapitiya, Devaki, Wheatley, Adam K., Tan, Hyon-Xhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154910/
https://www.ncbi.nlm.nih.gov/pubmed/37146404
http://dx.doi.org/10.1016/j.ebiom.2023.104585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154910/
https://www.ncbi.nlm.nih.gov/pubmed/37146404
http://dx.doi.org/10.1016/j.ebiom.2023.104585

Ejemplares similares